Effect of levosimendan on survival and adverse events after cardiac surgery: A meta-analysis

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 27, Issue 6, 2013, Pages 1224-1232

  Harrison, Robert W ^a   Hasselblad, Vic ^a   Mehta, Rajendra H ^a   Levin, Ricardo ^b   Harrington, Robert A ^a   Alexander, John H ^a  

^a DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

cardiopulmonary bypass; heart failure; intensive care; meta analysis; statistics

Indexed keywords

DOBUTAMINE; LEVOSIMENDAN; MILRINONE;

ADVERSE OUTCOME; ARTICLE; CARDIOPULMONARY BYPASS; CARDIOVASCULAR MORTALITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY BYPASS GRAFT; DIALYSIS; ECHOCARDIOGRAPHY; FORWARD HEART FAILURE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE INJURY; HEART SURGERY; HUMAN; INFUSION RATE; INTRAAORTIC BALLOON PUMP; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURGICAL PATIENT; SURVIVAL;

CARDIOPULMONARY BYPASS; HEART FAILURE; INTENSIVE CARE; META-ANALYSIS; STATISTICS;

CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; DATA INTERPRETATION, STATISTICAL; HOSPITAL MORTALITY; HUMANS; HYDRAZONES; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PUBLICATION BIAS; PYRIDAZINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RISK ASSESSMENT; STROKE VOLUME; SURVIVAL; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84888296344     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2013.03.027     Document Type: Article

References (47)

1. T.B. Ferguson Jr, B.G. Hammill, and E.D. Peterson A decade of change-risk profiles and outcomes for isolated coronary artery bypass grafting procedures, 1990-1999: A report from the STS National Database Committee and the Duke Clinical Research Institute Ann Thorac Surg 73 2002 480 489
2. C.M. OÊConnor, E.J. Velazquez, and L.H. Gardner Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank) Am J Cardiol 90 2002 101 107
3. E.J. Velazquez, K.L. Lee, and M.A. Deja Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med 364 2011 1607 1616
4. D.M. Shahian, S.M. OÊBrien, and G. Filardo The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 1-coronary artery bypass grafting surgery Ann Thorac Surg 88 2009 S2 S22
5. V.K. Topkara, F.H. Cheema, and S. Kesavaramanujam Coronary artery bypass grafting in patients with low ejection fraction Circulation 112 2005 I344 I350
6. F. Filsoufi, P.B. Rahmanian, and J.G. Castillo Results and predictors of early and late outcome of coronary artery bypass grafting in patients with severely depressed left ventricular function Ann Thorac Surg 84 2007 808 816
7. F. Follath, J.G. Cleland, and H. Just Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial Lancet 360 2002 196 202
8. A. Mebazaa, M.S. Nieminen, and M. Packer Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE Randomized Trial JAMA 297 2007 1883 1891
9. J.G. Cleland, N. Freemantle, and A.P. Coletta Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE European Journal of Heart Failure 8 2006 105 110
10. G. Landoni, A. Mizzi, and G. Biondi-Zoccai Reducing mortality in cardiac surgery with levosimendan: A meta-analysis of randomized controlled trials J Cardiothorac Vasc Anesth 24 2010 51 57
11. G. Landoni, G. Biondi-Zoccai, and M. Greco Effects of levosimendan on mortality and hospitalization: A meta-analysis of randomized controlled studies Crit Care Med 40 2012 634 646
12. R. Levin, M. Degrange, and C.D. Del Mazo Preoperative levosimendan decreases mortality and development of low cardiac output in high-risk patients with severe left ventricular dysfunction undergoing coronary artery bypass grafting with cardiopulmonary bypass Exp Clin Cardiol 17 2012 125 130
13. Lefebvre C, Manheimer E, Glanville J: Searching for studies, in Higgins JPT, Green S (eds): Cochrane Handbook for Systematic Reviews of Interventions. http://www.cochrane.org/handbook/chapter-6-searching-studies, The Cochrane Collaboration, 2011
14. S.S. Wong, N.L. Wilczynski, and R.B. Haynes Developing optimal search strategies for detecting clinically sound treatment studies in EMBASE J Med Libr Assoc 94 2006 41 47
15. Higgins JPT, Green S: Cochrane Handbook for Systematic Reviews of Interventions. http://www.cochrane-handbook.org/, The Cochrane Collaboration, 2011
16. V. Hasselblad, F. Mosteller, and B. Littenberg A survey of current problems in meta-analysis. Discussion from the Agency for Health Care Policy and Research inter-PORT Work Group on Literature Review/Meta-Analysis Medical Care 33 1995 202 220
17. K. Jarvela, P. Maaranen, and T. Sisto Levosimendan in aortic valve surgery: Cardiac performance and recovery J Cardiothorac Vasc Anesth 22 2008 693 698
18. J. Alvarez, M. Bouzada, and A.L. Fernandez Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery Rev Esp Cardiol 59 2006 338 345
19. J. Alvarez, M. Taboada, and J. Rodriguez Hemodynamic effects of levosimendan following cardiac surgery Rev Esp Anestesiol Reanim 52 2005 389 394
20. R. Levin, R. Porcile, and F. Salvagio Levosimendan reduces mortality in postoperative low cardiac output syndrome after coronary surgery Circulation 120 2009 S987 S988
21. E. Al-Shawaf, A. Ayed, and I. Vislocky Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery J Cardiothorac Vasc Anesth 20 2006 353 357
22. L. Tritapepe, V. De Santis, and D. Vitale Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery Br J Anaesth 102 2009 198 204
23. L. Tritapepe, V. De Santis, and D. Vitale Preconditioning effects of levosimendan in coronary artery bypass grafting: A pilot study Br J Anaesth 96 2006 694 700
24. H.I. Eriksson, J.R. Jalonen, and L.O. Heikkinen Levosimendan facilitates weaning from cardiopulmonary bypass in patients undergoing coronary artery bypass grafting with impaired left ventricular function Ann Thorac Surg 87 2009 448 454
25. H. Leppikangas, K. Jarvela, and T. Sisto Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery Br J Anaesth 106 2011 298 304
26. P. Lahtinen, O. Pitkanen, and P. Polonen Levosimendan reduces heart failure after cardiac surgery: A prospective, randomized, placebo-controlled trial Crit Care Med 39 2011 2263 2270
27. S.G. De Hert, S. Lorsomradee, and S. Cromheecke The effects of levosimendan in cardiac surgery patients with poor left ventricular function Anesth Analg 104 2007 766 773
28. M. Momeni, J. Rubay, and A. Matta Levosimendan in congenital cardiac surgery: A randomized, double-blind clinical trial J Cardiothorac Vasc Anesth 25 2011 419 424
29. V.V. Lomivorotov, A.M. Cherniavskiy, and V.A. Boboshko Levosimendan vs. intra-aortic balloon pump in high-risk cardiac surgery Asian Cardiovasc Thorac Ann 19 2011 154 159
30. R. Maharaj, and V. Metaxa Levosimendan and mortality after coronary revascularisation: A meta-analysis of randomised controlled trials Crit Care 15 2011 R140
31. G. Landoni, A. Mizzi, and G. Biondi-Zoccai Levosimendan reduces mortality in critically ill patients: A meta-analysis of randomized controlled studies Minerva Anestesiol 76 2010 276 286
32. D.M. Shahian, S.M. OÊBrien, and G. Filardo The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 1-coronary artery bypass grafting surgery Ann Thorac Surg 88 2009 S2 S22
33. K.D. Algarni, M. Maganti, and T.M. Yau Predictors of low cardiac output syndrome after isolated coronary artery bypass surgery: Trends over 20 years Ann Thorac Surg 92 2011 1678 1684
34. J.L. Fellahi, J.J. Parienti, and J.L. Hanouz Perioperative use of dobutamine in cardiac surgery and adverse cardiac outcome: Propensity-adjusted analyses Anesthesiology 108 2008 979 987
35. S. Thackray, J. Easthaugh, and N. Freemantle The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure: A meta-regression analysis European Journal of Heart Failure 4 2002 515 529
36. A. Mebazaa, A.A. Pitsis, and A. Rudiger Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery Crit Care 14 2010 201
37. H. Parissis, M. Leotsinidis, and M.T. Akbar The need for intra aortic balloon pump support following open heart surgery: Risk analysis and outcome Journal of Cardiothoracic Surgery 5 2010 20
38. M.S. Nieminen, J. Akkila, and G. Hasenfuss Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure J Am Coll Cardiol 36 2000 1903 1912
39. C.H. Bergh, B. Andersson, and U. Dahlstrom Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers European Journal of Heart Failure 12 2010 404 410
40. M.B. Fowler, J.A. Laser, and G.L. Hopkins Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: Progressive receptor down-regulation and subsensitivity to agonist response Circulation 74 1986 1290 1302
41. H. Ukkonen, M. Saraste, and J. Akkila Myocardial efficiency during levosimendan infusion in congestive heart failure Clinical Pharmacology and Therapeutics 68 2000 522 531
42. J. Lilleberg, M.S. Nieminen, and J. Akkila Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass grafting Eur Heart J 19 1998 660 668
43. S. Sonntag, S. Sundberg, and L.A. Lehtonen The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia J Am Coll Cardiol 43 2004 2177 2182
44. K. Meyer, R.C. Klocke, and J.D. Schipke Ca2+ sensitizer superior to catecholamine during myocardial stunning? Eur J Cardiothorac Surg 34 2008 326 331
45. L. Zanolla, and P. Zardini Selection of endpoints for heart failure clinical trials European Journal of Heart Failure 5 2003 717 723
46. L. Chen, J.Y. Tong, and H. Jin Long-term effects of bone marrow-derived cells transplantation in patients with acute myocardial infarction: A meta-analysis Chin Med J 126 2013 353 360
47. D.G. Katritsis, K.C. Siontis, and J.T. Bigger Effect of left ventricular ejection fraction and QRS duration on the survival benefit of implantable cardioverter-defibrillators: Meta-analysis of primary prevention trials Heart Rhythm 10 2013 200 206